Pharmaceutical - Santen Pharmaceuticals

Filter

Current filters:

Santen Pharmaceuticals

Popular Filters

More EMA/CHMP recommendations

23-01-2015

The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended approval…

Anti-viralsAntibiotics and Infectious diseasesCubistDutrebisEuropeIkervisMerck & CoOphthalmicsPharmaceuticalSanten PharmaceuticalsSivextro

Santen appoints Paolo Casati as manager of its new Italian operation

Santen appoints Paolo Casati as manager of its new Italian operation

11-12-2014

Ophthalmic specialist Santen has appointed Paolo Casati as general manager of Santen Italy, following…

BoardroomItalyOphthalmicsPharmaceuticalSanten Pharmaceuticals

Santen links with Singapore institute for new ophthalmics

14-11-2014

Japanese mid-size ophthalmic drugmaker Santen Pharmaceutical and the Singapore Eye Research Institute…

OphthalmicsPharmaceuticalResearchSanten Pharmaceuticals

Japan’s Santen sets up its own subsidiary in Italy

Japan’s Santen sets up its own subsidiary in Italy

15-10-2014

Japanese mid-size ophthalmic drugmaker Santen Pharmaceutical says it has established a wholly-owned subsidiary…

CosoptItalyMarkets & MarketingOphthalmicsPharmaceuticalSaflutanSanten Pharmaceuticals

Merck & Co sells ophthalmic brands and Colorado biologicals unit

Merck & Co sells ophthalmic brands and Colorado biologicals unit

13-05-2014

US pharma giant Merck & Co has entered into two more divestment transactions, following the recent sell-off…

KBI BiopharmaMerck & CoMergers & AcquisitionsOphthalmicsPharmaceuticalProductionSanten Pharmaceuticals

Santen and TRACON link up for TRC105 in ophthalmology

04-03-2014

USA-based TRACON Pharmaceuticals and Japan’s Santen Pharmaceutical have entered into an exclusive agreement…

LicensingPharmaceuticalSanten PharmaceuticalsTRACON PharmaceuticalsTRC105

Akorn gains rights to Betimol from Santen

10-01-2014

US niche generic firm Akorn has acquired the New Drug Application and all rights to Betimol (timolol…

AkornBetimolMergers & AcquisitionsOphthalmicsPharmaceuticalSanten Pharmaceuticals

Bayer files for Japanese approval of Eylea for macular edema following CRVO

07-01-2013

German drug major Bayer(BAYN: DE) says its subsidiary Bayer Yakuhin has applied to the Japanese Ministry…

afliberceptAsia-PacificBayerBiotechnologyEyleaOphthalmicsPharmaceuticalRegeneronRegulationSanten Pharmaceuticals

Santen in ophthalmics deal with Eisai; Sets up new company in China

26-09-2012

Japan's Santen Pharmaceutical (TYO: 4536) has entered into an option agreement with drug major Eisai…

Asia-PacificEisaiLicensingMarkets & MarketingOphthalmicsPharmaceuticalSanten Pharmaceuticals

Santen to co-promote Bayer and Regeneron's Eylea in Japan

09-05-2012

German drug major Bayer's (BAYN: DE) Japanese subsidiary, Bayer Yakuhin, and Santen Pharmaceutical (TYO:…

Asia-PacificBayerEyleaLicensingMarkets & MarketingOphthalmicsPharmaceuticalRegeneronSanten Pharmaceuticals

Back to top